| Last Price (SAR) | 62.20 |
| Prev. Close | 62.200 |
| Day Range | 61.90 - 63.30 |
| 52WK range | |
| Turnover (M SAR) | 2.57 |
| Volume (M) | 0.04 |
| Number of Trades | 548 |
| Market Cap (M SAR) | 2,177.00 |
| Change in Market Cap (M SAR) | |
| VWAP (SAR) | 0.00 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M SAR) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) extended a Sharia-compliant banking facility agreement with Banque...
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) renewed its Sharia-compliant banking facility agreement with Alinma...
Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) announced a net profit of SAR 55.70 million for the first half (H1) of...
Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next...
Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to...